Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MIST

Milestone Pharmaceuticals Inc

May 29 • 04:00PM ET

1.42

-0.02 -1.39 %

Healthcare • Biotechnology • Canada • Micro • NASD

Peers: HRTX KROS FENC MDWD NKTX OBIO RNAC SLGL ARCT VYGR

| Held by: SURI QQQS GWX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.68	Insider Own	1.03%	Shs Outstand	124.50M	Perf Week	-6.58%
Market Cap	176.79M	Forward P/E	-	EPS next Y	-1.02	Insider Trans	-28.97%	Shs Float	123.22M	Perf Month	-21.98%
Enterprise Value	129.90M	PEG	-	EPS next Q	-0.19	Inst Own	24.17%	Short Float	6.07%	Perf Quarter	-16.96%
Income	-68.36M	P/S	99.32	EPS this Y	-24.00%	Inst Trans	-1.67%	Short Ratio	3.68	Perf Half Y	-42.51%
Sales	1.78M	P/B	4.64	EPS next Y	-9.86%	ROA	-53.49%	Short Interest	7.48M	Perf YTD	-29.70%
Book/sh	0.31	P/C	0.96	EPS next 5Y	17.74%	ROE	-456.88%	52W High	3.06 -53.59%	Perf Year	-10.69%
Cash/sh	1.48	P/FCF	-	EPS past 3/5Y	18.24% 15.09%	ROIC	-39.58%	52W Low	1.00 42.00%	Perf 3Y	-64.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-32.38% -	Gross Margin	91.20%	Volatility	5.23% 6.82%	Perf 5Y	-76.53%
Dividend TTM	-	EV/Sales	72.98	EPS Y/Y TTM	17.64%	Oper. Margin	-3679.43%	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.09	Sales Y/Y TTM	-	Profit Margin	-3832.01%	RSI (14)	35.44	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	9.18	EPS Q/Q	36.11%	SMA20	-14.10%	Beta	0.96	Target Price	6.33
Payout	-	Debt/Eq	3.81	Sales Q/Q	-	SMA50	-14.76%	Rel Volume	0.25	Prev Close	1.44
Employees	38	LT Debt/Eq	3.79	Earnings	May 13 BMO	SMA200	-25.07%	Avg Volume	2.04M	Price	1.42
IPO	May 09, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-205.26% -99.21%	Trades		Volume	517,868	Change	-1.39%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)